Medical Devices DECODED
Previous edition: 16 May 2024
Share article
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
GE HealthCare and Medis partner on non-invasive coronary assessments
The companies will integrate Medis Medical’s non-invasive coronary physiology test, Medis QFR, with GE HealthCare’s cardiology Allia Platform.
GE Healthcare has partnered with Netherlands-based cardiac imaging software company Medis Medical Imaging to develop and commercialise non-invasive coronary assessments to diagnose and treat coronary artery disease (CAD).
As part of the collaboration, the companies will integrate Medis Medical’s non-invasive coronary physiology assessment, Medis Quantitative Flow Ratio (Medis QFR) with GE HealthCare’s interventional cardiology portfolio around Allia Platform.
The companies expect the collaboration to provide access to emerging technologies such as Medis QFR, as per the press release. At the same time, they intend to “reduce complexity in the cath lab and improve the operating environment for clinicians”.
CAD is caused by cholesterol plaque buildup in the wall of the coronary arteries. This causes the narrowing of the arteries over time which can result in an increased risk of major cardiovascular events, myocardial infarction and even death.
The disease is diagnosed by an invasive diagnostic procedure, coronary angiography, which allows clinicians to assess the patency of arteries and determine treatment. CAD treatment includes percutaneous coronary intervention (PCI) during which a catheter is used to place a stent to open blood vessels in the heart that have been narrowed by plaque buildup.
Medis QFR is a non-invasive, image-based alternative diagnostic approach for diagnosing CAD. It uses AI to analyse angiography imaging to help clinicians decide if PCI is needed and, if needed, to select the best PCI plan and efficacy.
A two-year study that compared the QFR-guided strategy of lesion selection for PCI with standard angiography guidance showed that QFR use was associated with improved two-year clinical outcomes, including a reduction in myocardial infarction and ischemia-driven revascularisation.
The use of AI has been increasing in radiology and imaging. GlobalData forecasts AI to be a key driver of medical device innovation. The AI market generated approximately $93bn in sales in 2023, as per GlobalData analysis.
GE Healthcare has expanded its offerings of AI imaging software in recent years. In November 2023, the company unveiled a set of AI integrations for breast cancer imaging. In January, it acquired a medical imaging company MIM Software, whose portfolio consists of AI-powered diagnostic imaging technologies.
Latest news
Atraverse receives approval for HOTWIRE Left Heart Access Device
The guidewire system is compatible with universal sheaths and features advanced RF technology.
Butterfly Network launches iQ+ Bladder in US
The iQ+ Bladder leverages the company's Ultrasound-on-Chip technology to provide a comprehensive bladder scanning solution.
Labcorp launches first trimester preeclampsia screening test
The new screening test needs to be conducted between 11 and 14 weeks of gestation for early detection of preeclampsia risk.
Study finds intravascular imaging effective for imaging the brain
The study into Spryte Medical’s neuro Optical Coherence Tomography device found that it was effective at gathering evidence of strokes and other neurological conditions.
Wondfo USA's Covid-19/Influenza Test receives FDA EUA approval
The authorisation allows healthcare providers to quickly distinguish between Covid-19 and influenza.
SPR Therapeutics reports positive data for PNS pain relief device
Cleveland based medical device company SPR Therapeutics announced a key milestone with the 10,000th patient treated using the SPRINT PNS System. The SPRINT System provides a low-risk alternative to opioids and does not require ablation, surgery, or permanent device implantation.
Boston Scientific on the importance of positive company culture at Cork facility
The medical device giant is consistently ranked as one of the top employers in Ireland but retaining skills and talent remains one of the company’s biggest challenges.
In our previous edition
Medical Devices Decoded
FDA issues recall notice for Philips after another respiratory device fails
15 May 2024
Medical Devices Decoded
FDA warns users not to use Cue Health's at-home Covid-19 tests
14 May 2024
Medical Devices Decoded
Dementia Action Week 2024: the future of Alzheimer's diagnostics
13 May 2024
Newsletters in other sectors
Aerospace, Defence & Security
Automotive
Banking & Payments
Medical Devices
Oil & Gas
Travel and Tourism
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer